Return On Equity of Evofem Biosciences, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Evofem Biosciences, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Evofem Biosciences, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 8%, a 33% decline year-over-year.
  • Evofem Biosciences, Inc. annual Return On Equity for 2024 was 13%.
  • Evofem Biosciences, Inc. annual Return On Equity for 2023 was -90%, a 245% decline from 2022.
  • Evofem Biosciences, Inc. annual Return On Equity for 2022 was 62%, a 87% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Evofem Biosciences, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 8% -4% -33% 01 Jul 2025 30 Sep 2025
Q2 2025 9% +101% 01 Apr 2025 30 Jun 2025
Q1 2025 4% +86% 01 Jan 2025 31 Mar 2025
Q4 2024 13% +103% 01 Oct 2024 31 Dec 2024
Q3 2024 11% +89% 01 Jul 2024 30 Sep 2024
Q2 2024 -92% +15% +14% 01 Apr 2024 30 Jun 2024
Q1 2024 -81% -126% -282% 01 Jan 2024 31 Mar 2024
Q4 2023 -90% -152% -245% 01 Oct 2023 31 Dec 2023
Q3 2023 -78% -169% -185% 01 Jul 2023 30 Sep 2023
Q2 2023 -107% -331% -148% 01 Apr 2023 30 Jun 2023
Q1 2023 45% -226% -83% 01 Jan 2023 31 Mar 2023
Q4 2022 62% -427% -87% 01 Oct 2022 31 Dec 2022
Q3 2022 91% -1159% -93% 01 Jul 2022 30 Sep 2022
Q2 2022 224% +1851% 01 Apr 2022 30 Jun 2022
Q1 2022 271% +973% 01 Jan 2022 31 Mar 2022
Q4 2021 489% +1001% 01 Oct 2021 31 Dec 2021
Q3 2021 1250% +1615% 01 Jul 2021 30 Sep 2021
Q2 2021 -1628% -1268% -352% 01 Apr 2021 30 Jun 2021
Q1 2021 -702% -278% -66% 01 Jan 2021 31 Mar 2021
Q4 2020 -512% +174% +25% 01 Oct 2020 31 Dec 2020
Q3 2020 -365% +3933% +92% 01 Jul 2020 30 Sep 2020
Q2 2020 -360% -1673% -127% 01 Apr 2020 30 Jun 2020
Q1 2020 -424% -948% -181% 01 Jan 2020 31 Mar 2020
Q4 2019 -686% -1769% -163% 01 Oct 2019 31 Dec 2019
Q3 2019 -4297% -4464% -2679% 01 Jul 2019 30 Sep 2019
Q2 2019 1313% +1063% +426% 01 Apr 2019 30 Jun 2019
Q1 2019 524% +296% +130% 01 Jan 2019 31 Mar 2019
Q4 2018 1082% +926% +592% 01 Oct 2018 31 Dec 2018
Q3 2018 167% -82% -33% 01 Jul 2018 30 Sep 2018
Q2 2018 250% +93% +59% 01 Apr 2018 30 Jun 2018
Q1 2018 228% +60% +36% 01 Jan 2018 31 Mar 2018
Q4 2017 157% -48% -23% 01 Oct 2017 31 Dec 2017
Q3 2017 249% -104% -30% 01 Jul 2017 30 Sep 2017
Q2 2017 157% -201% -56% 01 Apr 2017 30 Jun 2017
Q1 2017 168% -880% -84% 01 Jan 2017 31 Mar 2017
Q4 2016 204% +1016% 01 Oct 2016 31 Dec 2016
Q3 2016 354% +424% 01 Jul 2016 30 Sep 2016
Q2 2016 358% 01 Apr 2016 30 Jun 2016
Q1 2016 1049% 01 Jan 2016 31 Mar 2016
Q4 2015 -812% 01 Oct 2015 31 Dec 2015
Q3 2015 -71% 01 Jul 2015 30 Sep 2015

Evofem Biosciences, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 13% +103% 01 Jan 2024 31 Dec 2024
2023 -90% -152% -245% 01 Jan 2023 31 Dec 2023
2022 62% -427% -87% 01 Jan 2022 31 Dec 2022
2021 489% +1001% 01 Jan 2021 31 Dec 2021
2020 -512% +174% +25% 01 Jan 2020 31 Dec 2020
2019 -686% -1769% -163% 01 Jan 2019 31 Dec 2019
2018 1082% +926% +592% 01 Jan 2018 31 Dec 2018
2017 157% -44% -22% 01 Jan 2017 31 Dec 2017
2016 201% +1013% 01 Jan 2016 31 Dec 2016
2015 -812% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.